Apollo Hospitals approves major restructuring plans; to list digital health, pharmacy arms
ADVERTISEMENT Under the restructuring exercise, the company will first demerge its 'Identified Business Undertaking' into Apollo Healthtech. Subsequently, both AHL and Keimed Private Limited will be merged into Apollo Healthtech, consolidating critical operations under one roof.
Through this move, AHEL aims to unlock value through strategic reorganisation, enabling direct listing of its Omni Channel Pharmacy and Digital Health business, a company filing to the exchanges said.
"Composite Scheme creates a formidable Omni Channel Pharmacy Distribution and Digital Health platform leader in India, with scale of Rs 16,300 crores (US$1.9bn) of revenue in FY25, with stated plans to achieve Rs 25,000 crores revenue by FY27, with 7% EBITDA margin," the company filing added.Following this transaction, Apollo Healthtech Limited will seek listing of its equity shares on the NSE and BSE, paving the way for investors to participate directly in the reorganised entity.Additionally, Apollo disclosed an agreement signed on June 30, 2025, between Rasmeli Limited, an existing shareholder of AHL, and AHL promoter Shobana Kamineni. Rasmeli agreed to share a portion of its investment upside with the promoter and key employees, aligning interests and rewarding performance.
ADVERTISEMENT AHEL shareholders to have direct shareholding in a combined entity. For every 100 shares of AHEL, AHEL shareholders will receive 195.2 shares of the new entity. Listing of the entity is expected in 18-21 months, the company filing said.Commenting on the development, Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise, said, "This comprehensive integrated network, overlaid with a strong digital layer, will allow us to create an impact of magnitude greater than could be achieved with a single format of care. This proposal enables AHEL shareholders to gain direct shareholding in India's largest Omni-Channel Pharmacy and Digital Health Platform, enabling full value discovery and eliminating any hold co discount in valuation.
ADVERTISEMENT Meanwhile, AHEL will continue its focus on healthcare delivery, she added.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
(You can now subscribe to our ETMarkets WhatsApp channel)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
37 minutes ago
- NDTV
India-US Trade Talks In Advanced Stage, Agricultural Products A Hurdle: Official
New Delhi: The India-US trade negotiations are at an advanced stage and a consensus on an interim deal is within reach, a key official told NDTV on Tuesday, adding that Washington's demands on agricultural products are proving to be a hurdle. Indo-American Chamber of Commerce Executive Council Member Sunil Jain spoke to the channel on Tuesday, a day after Finance Minister Nirmala Sitharaman was reported as having said that agriculture and dairy are "big red lines" for India in the trade talks. "The deal has progressed a lot and the chief negotiators of India are extending their stay in the US and trying to complete the deal. I think the two areas where the deal is getting stuck are related to agricultural products. Agriculture is the lifeline of the Indian GDP and Indian people. It is very difficult for us to import agricultural products. There are many difficulties and sensitivities involved," Mr Jain said in Hindi. "The second thing is that the products the US sells to us are genetically modified products, which are banned in India. Till date, no law has been enacted in India to allow these products. So, it is very difficult for us to import maize, cotton, soya, almonds, apples, etc. The US is telling us to make a deal on these products," he added. The negotiations between India and the US entered the sixth day in Washington on Tuesday. The Indian team, headed by Rajesh Agrawal, special secretary in the Department of Commerce, was initially scheduled to stay for two days. The extension is important because US President Donald Trump's 26% reciprocal tariffs had been suspended for 90 days till July 9. The baseline tariffs of 10%, though, are still in place. "I think both countries can keep this obstacle aside and move forward with other products. For the US, exports of auto components, aluminium and steel from India are a problem. I think we should make a deal and keep some products out of it... We can debate and come to an agreement on these products after three to four months," he said. If this can be worked out, the executive council member said, a large part of India's exports to the US will be saved from the reciprocal tariffs, but the base tariff of 10% is likely to remain. "The zero tariff trade will be settled only after September-October. But, even if we work with 10% as the base tariff, it is fine for the country... If there is any bilateral trade agreement, it will have to involve give and take. So, we will move forward and America will move forward. Both are the largest democracies in the world and they will have to move together," Mr Jain said.
The Hindu
37 minutes ago
- The Hindu
T.N. CM Stalin to inaugurate new urban HWCs and PHCs
Chief Minister M.K. Stalin will inaugurate 208 urban Health and Wellness Centres (HWC) and 50 Primary Health Centres (PHC) and urban PHCs on July 3, according to Health Minister Ma. Subramanian. He said that the CM had earlier announced that 708 urban HWCs will be established in the State. Of this, 500 were opened within a year of announcement. The remaining 208 will be inaugurated by the CM through videoconferencing from a centre in Adyar. Each urban HWC will have a doctor, nurse, health inspector and support staff. He added that 19 new district headquarters hospitals and six hospitals on par with district headquarters hospitals were being established at a cost of Rs. 1,018 crore. Of this, the district headquarters hospital at Tiruttani was already inaugurated. Recruitment of staff will be taken up for the remaining 24 hospitals soon, he said.
Time of India
38 minutes ago
- Time of India
Ghaziabad hospital told to pay retired railway employee s 17k for claim process delay
Ghaziabad: District Consumer Disputes Redressal Commission (DCDRC) has directed the Northern Railways chief medical superintendent (CMS) to pay over Rs 17,000 to a retired railway employee — as reimbursement and compensation for claim delay. While payment of Rs 12,398 has been ordered as treatment reimbursement for cataract surgery, that of Rs 5,000 has been directed as the compensation for delaying the payment of the claim. The commission also directed the payment to be made within 45 days of the order, failing which interest calculated at 6% would have to be paid. You Can Also Check: Noida AQI | Weather in Noida | Bank Holidays in Noida | Public Holidays in Noida Passing the order on June 23, the commission, presided over by Praveen Kumar Jain, said railway authorities should have taken necessary steps to initiate payment instead of rejecting the claim on the grounds of incomplete papers "when the claimant is a retired employee of the railways". Devilal Singh, who superannuated from the post of chief medical superintendent (CMS) in 2012, had filed an application before the DCDRC for direction to CMS, Delhi divisional office and assistant chief medical superintendent (ACMS) of Railway Hospital Ghaziabad. The complainant said during retirement, he was provided with a medical card covering him and his family members. He told the commission, "When I felt some problem with my right eye, I consulted the doctors at JP Hospital, Noida, and underwent a surgery on April 10, 2019, for which I paid Rs 35,890. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Once again, I had some issues with my right eye and was advised by doctors at JP Hospital to undergo a cataract surgery, which was conducted on Oct 1, 2019. This time, I paid Rs 30,500 towards the bills raised by the hospital. When I applied for reimbursement of the treatment cost with ACMS (Railway Hospital Ghaziabad) with all relevant documents, it was rejected, which was not just a deficiency in services but also illegal. " The complainant later filed an RTI application and was informed by the railways that his first claim of Rs 35,890 was settled by the railway department by paying Rs 1,786, as was admissible under the policy of Central Govt Health Service (CGHS). The complainant contended that since he was an employee of the railway, his claims could not be dealt with under the CGHS policy and were governed by the railway board. The counsel for the opponents said that railway authorities follow the railway board policy of 2005, effective since Jan 2007, under which beneficiaries can obtain treatment at hospitals recognised by the railways. "The beneficiaries are free to obtain treatment at any hospital of their choice, but in that case, reimbursement is done according to CGHS rates as applicable," the counsel said. He told the commission the second claim was rejected for inadequacy of documents. Get the latest lifestyle updates on Times of India, along with Doctor's Day 2025 , messages and quotes!
